在冠状动脉疾病中识别枢纽基因和免疫透:风险预测模型
Wenchao Xie1, Wang Liao1, Hongming Lin2
1Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Journal of inflammation research
|November 18, 2024
概括
这项研究开发了一种新的模型,通过分析基因表达和免疫细胞透来预测冠状动脉疾病 (CAD) 风险. 该模型准确地识别高风险患者,为早期发现和管理CAD提供了有价值的工具.
科学领域:
- 基因组学就是基因组学.
- 免疫学 免疫学 免疫学
- 心血管研究研究心血管研究
背景情况:
- 冠状动脉疾病 (CAD) 是一个重大的全球健康挑战.
- 准确的风险预测模型对于有效的CAD管理和预防至关重要.
- 整合分子数据,如基因表达和免疫透,可以改善CAD风险评估.
研究的目的:
- 开发和验证冠状动脉疾病 (CAD) 的新型预测模型.
- 整合免疫透模式和基因表达特征,以提高CAD风险预测.
- 确定关键的分子参与者和涉及CAD病变发生的途径.
主要方法:
- 在GSE113079数据集上进行了差异基因表达分析,以确定差异表达基因 (DEG) 和枢纽基因.
- 进行了途径丰富分析,以了解已识别的基因的生物功能.
- 建立了差异表达微RNA (DEmiRNA) 和DEGs的调节网络.
- 拉索算法被用来构建一个结合风险和免疫评分的CAD风险预测模型.
- 模型性能使用接收器操作特征-曲线下的区域 (ROC-AUC) 分析和聚合酶链反应 (PCR) 进行了验证.
主要成果:
- 确定了613个DEG和12个枢纽基因,主要与免疫和炎症反应有关.
- 六个枢纽基因 (PTGER1,PIK3R1,ADRA2A,CORT,CXCL12,S1PR5) 显示出高的预测能力 (AUC>0.90).
- 使用拉索回归开发了一种新的CAD风险预测模型,达到0.988.98的高AUC.
- PCR验证证实了CAD中关键枢纽基因的表达模式.
结论:
- 该研究成功开发了一种强大的CAD风险预测模型,整合了基因表达和免疫透.
- 已识别的枢纽基因及其分子机制为CAD病原体提供了洞察力.
- 开发的模型是预测CAD风险的宝贵工具,可能有助于早期诊断和个性化治疗策略.
相关概念视频
Genome-wide Association Studies-GWAS
12.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.5K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
60
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
60


